Take Solutions Surges 5% on Q4 Earnings, Hits Upper Circuit

Take Solutions Share Price Hits Upper Circuit After Q4 Results

Take Solutions, a small-cap stock with a market value under ₹50, witnessed a significant surge in its share price on Thursday, reaching an upper circuit of ₹27.98. This impressive gain comes after the company reported a turnaround in profitability during the March quarter, driven by a recovery in operations and a continued focus on healthcare technology and AI-driven businesses.

The scrip had been facing a challenging period, with its share price declining by 43% in the past month and 40% in the last three months. However, Take Solutions has delivered multibagger returns in the last year, with a staggering 180% rise. The stock had previously touched its 52-week high of ₹49.90 in February 2026 and its 52-week low of ₹8.16 in June 2025.

Read also: SpaceX Seeks Record $75 Billion IPO, Potentially Positioning Elon Musk as the World's First Trillionaire

Take Solutions' Q4 results showcased a significant operational improvement for the company, which has been focusing on expanding its presence across healthcare technology, artificial intelligence, and digital health solutions. The company reported a consolidated net profit of ₹4.36 crore for the quarter ended March 2026, compared to a net loss of ₹4.88 crore recorded during the corresponding quarter of the previous financial year.

Despite the quarterly turnaround, the company's full-year profitability declined sharply on a year-on-year basis. For FY26, net profit fell 71.04% to ₹10.85 crore, compared to ₹37.47 crore reported during FY25. The company reported annual revenue of ₹54.19 crore for the financial year ended March 2026, while no revenue had been reported during the previous financial year.

Take Solutions continued strengthening its focus on AI-led healthcare solutions and innovation-driven businesses during FY26. As part of this strategy, the company launched a ₹5 crore Innovation Fund aimed at supporting startups operating in artificial intelligence, deep technology, and digital healthcare segments. The company also expanded its presence in the health and wellness space through its AI-driven platform, Take.Health, which remains a key part of its long-term digital healthcare strategy.

Parmeshvar Dhangare, Director of Take Solutions Limited, noted that FY26 marked an important phase for strengthening the company's position across healthcare technology and digital solutions businesses. He added that the company expanded its AI-driven healthcare capabilities through Take.Health while simultaneously building a stronger innovation ecosystem through the newly launched Innovation Fund.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data